BioAim Scientific (Kanada)
The Bioaim Human MMP-13 ELISA kit is a solid phase sandwich ELISA (enzyme-linked immunosorbent assay) for the quantitative measurement of MMP-13 in human serum and plasma. An antibody specific for human MMP-13 was coated on a 96-well plate. Standards and samples are added to the wells and any MMP-13 present binds to the immobilized antibody. The wells are washed and biotinylated anti-human MMP-13 antibody is added. After washing away unbound biotinylated antibody, HRP-conjugated streptavidin is added to the wells. The wells are again washed and TMB substrate solution is added, which produces a blue color in direct proportion to the amount of MMP-13 present in the initial sample. The Stop Solution changes the color from blue to yellow, and the microwell absorbances are read at 450 nm.Research Area Angiogenesis; Cancer Biomarker;
matrix metallopeptidase 13( MMP-13 ) Background: MMP-13 is a member of the matrix metalloproteinase (MMP) family. Like most MMPs, it is secreted as an inactive pro-form. It is activated once the pro-domain is cleaved, leaving an active enzyme composed of the catalytic domain and the hemopexin-like domain PDB:1PEX. Although the actual mechanism has not been described, the hemopexin domain participates in collagen degradation, the catalytic domain alone being particularly inefficient in collagen degradation. During embryonic development, MMP13 is expressed in the skeleton as required for restructuring the collagen matrix for bone mineralization. In pathological situations it is highly overexpressed; this occurs in human carcinomas, rheumatoid arthritis and osteoarthritis.
CLG3, MANDP1, MDST, MMP-13
Serum, plasma, Cell culture supernatant
|Antigen Name||matrix metallopeptidase 13|
|Detection Range||8.2-6000 pg/ml|
|Alias||CLG3, MANDP1, MDST, MMP-13|